John W. Barrett

About

John W. Barrett is a leading clinician-researcher in head and neck oncology, with a focus on human papillomavirus (HPV)-related oropharyngeal cancers and transoral robotic surgery (TORS). His major contributions include pioneering high-throughput drug testing to identify agents with preferential activity in HPV-positive versus HPV-negative head and neck squamous cell carcinoma cell lines, a study that has garnered 15 citations and opened new avenues for personalized therapy. Barrett also advanced the understanding of modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy, demonstrating excellent survival and toxicity profiles in a 13-cited study that informs clinical decision-making. Notably, he played a key role in developing Canada’s first TORS program at Western University, overcoming unique healthcare barriers to bring robotic surgery to Canadian patients—a landmark achievement documented in a 5-cited paper. His work bridges translational research and clinical innovation, directly impacting treatment paradigms for head and neck cancer patients. With a career marked by high-impact studies and pioneering surgical programs, Barrett continues to shape the future of oncologic care.

Research Focus

Key Achievements

Top Papers

1. 1
   High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines

   15 citations · 2018
2. 2
   Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution

   13 citations · 2020
3. 3
   Development of a transoral robotic surgery program in Canada

   5 citations · 2013

Key Collaborators

Contact & Links